Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Platinum-Gemcitabine-Avastin (PGA) for Platinum-resistant/Refractory Ovarian and Peritoneal Carcinoma
NCT01936974Phase 2Terminated
- Sponsor
- Western Regional Medical Center
- Start
- Sep 2013
- Primary completion
- Aug 2015
- Modality
- DNA Intercalators/Alkylators
- Countries
- 1
01
Overview
A Phase 2 trial of carboplatin, cisplatin, oxaliplatin in ovarian carcinoma, fallopian tube carcinoma (PFTC), primary peritoneal carcinoma (PPC), sponsored by Western Regional Medical Center. Started Sep 2013; status: terminated.
02
Drugs
carboplatincisplatinoxaliplatin
03
Conditions
ovarian carcinomafallopian tube carcinoma (PFTC)primary peritoneal carcinoma (PPC)
Beyond the preview
Go deeper on NCT01936974.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01936974.